2The Board of Trustees The United States Pharmacopoeia 26& the National Formulary 19 [S].Rockville:The United States PharmacopeialConvention,2003.767 768
3Francois L, Sonia G, Fabienne D, et al. Development and valida tion of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine[ J ]. J Pharm Biomed Anal ,2002,30(Suppl 4) :S897 - S911.
4Forsman U, Andersson M, Tornros H. Ion-exchange chromatography with post-column reaction for the analysis of phosphonoformance, phosphate and phosphate[ J ]. J Chromatogr, 1986,369 (1):151- 157.
5Takashi U,Takashi W,Saburo H. Determination of a new dispho sphonate, YM175, in plasma, urine and bone by high -performance liquid chromatography with electrochemical detection[J ]. J Chromatogr, 1992,584(2): 213 - 220.
6Siris ES,Chinese AA,Altman RD,et al.Risedronate in the treatment of Paget′s disease of bone:an open label,multicenter study.J Bone Miner Res,1998,13(6):1032-1038.
